Navigation Links
Consumer not ready for tailor-made nutrition
Date:11/4/2008

In the near future it will be possible to customise the food we eat to individual needs, based on the genetic profile of the individual. Dutch researcher Amber Ronteltap suggests that the consumer market is not yet ready for this so-called nutrigenomics. Ronteltap concludes that many obstacles must be overcome before products based on nutrigenomics become a reality.

Nutrigenomics is a discipline that investigates the correlation between nutrients and the human genome. This area of science can contribute to public health and disease prevention by providing individuals with advice on specific adaptations in their nutrient regime. This form of personalised nutrition joins the bandwagon of broader marketing trends to develop products more tailored to the individual.

Experts

For her doctoral research, Amber Ronteltap interviewed 29 experts from trade and industry, civil organisations, government, media and science. These interviews reveal that there is poor consensus on important questions such as: What exactly is nutrigenomics, within what time frame will it be usable in practice, and how is acceptance by consumers determined?

Consumers

Based on these interviews with experts and an extensive literature study, Ronteltap developed different future scenarios to put to the general public. A representative random sample generated a number of conditions that consumers would require before accepting nutrigenomics. The most important is freedom of choice: the guarantee that it would not be compulsory to register a genetic profile. The consumer also believes that the products being developed should provide proven (health) benefits and that their use should not disrupt the routine of daily life. The general public also wants to see clear scientific agreement about the usefulness of the possibilities provided by nutrigenomics.

Conclusions

As well as assessing the opinions of experts and cons
'/>"/>

Contact: A.R. (Amber) Ronteltap
Amber.Ronteltap@wur.nl
31-317-484-432
Netherlands Organization for Scientific Research
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cheskin Added Value EVP Lee Shupp Discusses Evolving Dynamics of Consumers and Imaging Tech at 6Sight
2. Consumers influence christmas tree styles
3. Department of Energy putting power in the hands of consumers through technology
4. Direct-to-consumer advertising for genetic tests concerns physicians and may mislead patients
5. Shell Provides Consumers Gasoline Industrys First Pay By Touch Technology at the Pump
6. Alternative food networks connect ethical producers and consumers and can lead to healthier eating
7. Got calcium? UWM researcher finds that food labels confuse consumers
8. New test could help consumers avoid surprise headaches from chocolate, wine
9. Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready
10. Pacific shellfish ready to invade Atlantic
11. Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ration is now open for the Society of Intervention...gy (IO) Therapies" Webinar, which will provide the...treatment of liver tumors, kidney tumor ablation a...tion of physicians, scientists and allied health p...through pioneering advances in image-guided therap...
(Date:11/6/2009)... generally live in harmony with their arboreal hos...ut of space in their trees of choice, the ants can...earch, published in the November issue of the Ame...nts bore into live trees, and it reopens a centuri... plants. , Ants and certain species of plants an...
(Date:11/6/2009)...mber 06, 2009) The Monell Center and the Chinese ...ing International Meeting on Taste and Smell Resea... CAS, the meeting will be the first international ... Alan Leshner, Chief Executive Officer, American ...cutive Publisher of Science magazine, will open th...
Breaking Biology News(10 mins):Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2Ants are friendly to some trees, but not others 2Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 1Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 2Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 3Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 4Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 5Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 6Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 7Sharing Miracles Television Program to Feature Legendary Rapper and Popular Actor Ice T 50540 8XLHealth Appoints New Vice President of Contracting and Provider Relations 50536 1XLHealth Appoints New Vice President of Contracting and Provider Relations 50536 2Siblings target of intervention program 50533 1
...Swedish amateur boxers suggests that they have hig...inal fluid in the days following a bout, indicatin... brain function, according to a report in the Sept...AMA/Archives journals. , About 20 percent of profe...ury, according to background information in the ar...
... researchers have devised a way to use a brief bur...particles from a tiny gold launch pad. The techniq... of medicine on command from a chip implanted in t... reactions that require the controlled release of ...echnique was described Sept. 10 in a presentation ...
...s found that close to half of 154 smokers who had ...p a cigarette again within 12 months of their pot...rd were smoking at the one year mark. Sixty percen...hin two months of surgery. , The study, led by res...ne and published in the December issue of Cancer E...
Other Biology News:Amateur boxing linked to brain cell injury 2Electric jolt triggers release of biomolecules, nanoparticles 2Successful lung cancer surgery not enough to break nicotine dependence in many smokers 2Successful lung cancer surgery not enough to break nicotine dependence in many smokers 3
(Date:11/9/2009)... BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yo...e or "the Company") a leading manufacturer, develo... animal nutrient products in the,People,s Republic...uct a,conference call at 10:00 a.m. Eastern Time (...009 to discuss results for the quarter ended Septe...
(Date:11/9/2009)... DIEGO, Nov. 9 NexBio, Inc. announ...l American College of Allergy, Asthma, and Immunol...led "DAS181 (Fludase®), a Sialidase, Decrease...ry Effects in Animal Models of Asthma". ,, DAS1...pectrum host-targeting drug candidate being studie...
(Date:11/9/2009)... LONDON, November 9 Following the ...S Food and Drug Administration (FDA), privately,ow...//www.davalinternational.com ) has been informed t...(R) has been awarded an Orphan-Drug,designation fo...ALS). , ALS, also known as Lou Gehrig,s d...
(Date:11/6/2009)...ONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Bio...it has re-filed the Form 52-109F1 Certification of...tive Officer and James Long, the Chief Financial O...y 12, 2009 in connection with the annual audited f...0, 2008. ,, The Company initially filed the ann...
Breaking Biology Technology:Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3
...s, CEO of ReBuilder,Medical Technologies, Inc. (Pi... ),will be featured in an exclusive interview with...th. The interview will be posted on http://www.wa...terview will cover topics including ReBuilder Medi...initiatives, competitive,edge, recent news, and mi...
...Call/ - Quest PharmaTech Inc. (TSX,Venture Exchang...ement with,a multinational technology development ...develop oncology products based on its SonoLight T... Pharma Tech Inc. ("Quest" or the,"Company") has a...000,000,will be paid within the next twelve months...
...phagenics,Limited ("Phosphagenics") (ASX: POH, AIM...lts of its Phase 1 clinical trial that showed its,...elief drug oxycodone,through the skin without caus...results support Phosphagenics, aims to be the firs...codone patch for the management of,chronic pain., ...
Other Biology Technology:WallSt.net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 3
Mouse Anti-Human Actopaxin, phospho (Ser8) Monoclonal Antibody, Unconjugated, Clone J160-366 from BD Biosciences Pharmingen
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Mouse Anti-Mouse Ly 6C.2(Ly 28.2) Monoclonal Antibody, Unconjugated, Clone 5075-3.6 from CEDARLANE Laboratories Limited
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Biology Products: